Page last updated: 2024-10-16

anthranilic acid and Atherosclerosis

anthranilic acid has been researched along with Atherosclerosis in 1 studies

anthranilic acid: RN given refers to parent cpd; structure in Negwer, 5th ed, #565
anthranilic acid : An aminobenzoic acid that is benzoic acid having a single amino substituent located at position 2. It is a metabolite produced in L-tryptophan-kynurenine pathway in the central nervous system.

Atherosclerosis: A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA.

Research Excerpts

ExcerptRelevanceReference
"Atherosclerosis is the major cause of cardiovascular disease (CVD), the leading cause of death worldwide."1.42Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development. ( Astola, N; Cole, JE; Cribbs, AP; Davies, AH; Feldmann, M; Goddard, ME; Green, P; Monaco, C; Park, I; Williams, RO, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cole, JE1
Astola, N1
Cribbs, AP1
Goddard, ME1
Park, I1
Green, P1
Davies, AH1
Williams, RO1
Feldmann, M1
Monaco, C1

Other Studies

1 other study available for anthranilic acid and Atherosclerosis

ArticleYear
Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development.
    Proceedings of the National Academy of Sciences of the United States of America, 2015, Oct-20, Volume: 112, Issue:42

    Topics: Animals; Apolipoproteins E; Atherosclerosis; Cinnamates; Drug Design; Indoleamine-Pyrrole 2,3,-Dioxy

2015